IQVIA Pharma Deals Review of 2025
By Lucy Haggerty,Taskin Ahmed, Ayush Saxena & Shikha Kashyap
Pharma Deals Review: Vol 2026 Issue 3 (Table of Contents)
Published: 27 Mar-2026
DOI: 10.3833/pdr.v2026.i3.3003 ISSN: 1756-7874
Section: Opinion & Analysis
Fulltext:
Abstract
Following an uneventful 2024, the slowdown in deal activity in the life sciences sector continued in 2025 as persistent macroeconomic headwinds, heightened geopolitical tensions and shifts in US healthcare policy discouraged companies from signing M&A,licensing and collaborative R&D deals over the course of the year...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS